Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

[Preliminary Study on the Wnt5a Expression in Obese Mice with Hepatocellular Carcinoma].

He H, Liang LB, Wang X, Wang XX, Wu YT, Li SQ, An ZM.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2017 Jan;48(1):12-16. Chinese.

PMID:
28612551
2.

SphK1 inhibitor SKI II inhibits the proliferation of human hepatoma HepG2 cells via the Wnt5A/β-catenin signaling pathway.

Liu H, Zhang CX, Ma Y, He HW, Wang JP, Shao RG.

Life Sci. 2016 Apr 15;151:23-29. doi: 10.1016/j.lfs.2016.02.098. Epub 2016 Mar 2.

PMID:
26944438
3.

Wnt5a involved in regulation of the biological behavior of hepatocellular carcinoma.

Bi L, Liu X, Wang C, Cao Y, Mao R, Li P, Geng M.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):987-95. eCollection 2014.

4.

An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis.

Hanaki H, Yamamoto H, Sakane H, Matsumoto S, Ohdan H, Sato A, Kikuchi A.

Mol Cancer Ther. 2012 Feb;11(2):298-307. doi: 10.1158/1535-7163.MCT-11-0682. Epub 2011 Nov 18.

5.

Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells.

Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, Yasui W, Kikuchi A.

Gastroenterology. 2009 Jul;137(1):242-52, 252.e1-6.

PMID:
19582886
6.
7.

The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.

Säfholm A, Tuomela J, Rosenkvist J, Dejmek J, Härkönen P, Andersson T.

Clin Cancer Res. 2008 Oct 15;14(20):6556-63. doi: 10.1158/1078-0432.CCR-08-0711.

Supplemental Content

Loading ...
Support Center